The integrated proteogenomic studies demonstrated that metabolic reprogramming in HBV-related HCC [9], namely involving PYCR2, ADH1A, et al. was associated with proteomic sub-grouping and played a role within the metabolic remodeling of HCC. The gene discussed is PYCR2; the disease is hepatocellular carcinoma.